Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $3.9 Million - $5.08 Million
-95,850 Reduced 14.54%
563,560 $26.3 Million
Q2 2022

Aug 15, 2022

BUY
$40.85 - $77.67 $404,292 - $768,699
9,897 Added 1.52%
659,410 $28.9 Million
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $9.85 Million - $15.1 Million
164,378 Added 33.88%
649,513 $47 Million
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $7.49 Million - $11.2 Million
92,349 Added 23.51%
485,135 $39.3 Million
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $2.64 Million - $4.3 Million
-25,859 Reduced 6.18%
392,786 $45.7 Million
Q2 2021

Aug 16, 2021

SELL
$141.6 - $179.06 $3.71 Million - $4.7 Million
-26,232 Reduced 5.9%
418,645 $69.4 Million
Q1 2021

May 17, 2021

BUY
$132.81 - $182.18 $17.7 Million - $24.2 Million
132,937 Added 42.62%
444,877 $62.1 Million
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $869,365 - $1.16 Million
-6,292 Reduced 1.98%
311,940 $54 Million
Q3 2020

Nov 16, 2020

BUY
$114.09 - $145.51 $24.4 Million - $31.1 Million
214,052 Added 205.46%
318,232 $44.3 Million
Q2 2020

Aug 14, 2020

BUY
$89.45 - $129.85 $9.32 Million - $13.5 Million
104,180 New
104,180 $12.4 Million
Q1 2020

May 15, 2020

SELL
$70.23 - $144.31 $40.5 Million - $83.3 Million
-577,163 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $13.8 Million - $21.3 Million
180,893 Added 45.65%
577,163 $67.8 Million
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $26.7 Million - $39.6 Million
-434,564 Reduced 52.3%
396,270 $34.1 Million
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $6.36 Million - $7.34 Million
109,605 Added 15.2%
830,834 $53.9 Million
Q1 2019

May 15, 2019

BUY
$35.52 - $62.62 $5.87 Million - $10.3 Million
165,134 Added 29.7%
721,229 $45.1 Million
Q4 2018

Feb 14, 2019

BUY
$35.43 - $56.29 $19.7 Million - $31.3 Million
556,095 New
556,095 $21.6 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.